171 related articles for article (PubMed ID: 17982156)
21. Physical activity and risk of ovarian cancer: a prospective cohort study in the United States.
Hannan LM; Leitzmann MF; Lacey JV; Colbert LH; Albanes D; Schatzkin A; Schairer C
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):765-70. PubMed ID: 15159308
[TBL] [Abstract][Full Text] [Related]
22. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
[TBL] [Abstract][Full Text] [Related]
23. Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GVHD and receiving glucocorticoid therapy.
Hovi L; Saarinen-Pihkala UM; Taskinen M; Wikström AM; Dunkel L
Bone Marrow Transplant; 2004 Mar; 33(5):503-8. PubMed ID: 14716348
[TBL] [Abstract][Full Text] [Related]
24. Breastfeeding and risk of ovarian cancer in two prospective cohorts.
Danforth KN; Tworoger SS; Hecht JL; Rosner BA; Colditz GA; Hankinson SE
Cancer Causes Control; 2007 Jun; 18(5):517-23. PubMed ID: 17450440
[TBL] [Abstract][Full Text] [Related]
25. Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women.
Larsson SC; Akesson A; Wolk A
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):994-7. PubMed ID: 19223560
[TBL] [Abstract][Full Text] [Related]
26. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer.
Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2304-13. PubMed ID: 18006919
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of serum androgen levels in women with premature ovarian failure.
Benetti-Pinto CL; Bedone AJ; Magna LA
Fertil Steril; 2005 Feb; 83(2):508-10. PubMed ID: 15705407
[TBL] [Abstract][Full Text] [Related]
29. Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study.
Kuijsten A; Hollman PC; Boshuizen HC; Buijsman MN; van 't Veer P; Kok FJ; Arts IC; Bueno-de-Mesquita HB
Am J Epidemiol; 2008 Mar; 167(6):734-42. PubMed ID: 18192676
[TBL] [Abstract][Full Text] [Related]
30. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
31. Gender of offspring and maternal risk of invasive epithelial ovarian cancer.
Baik I; Lambe M; Liu Q; Cnattingius S; Mucci LA; Riman T; Ekbom A; Adami HO; Hsieh CC
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2314-20. PubMed ID: 18006920
[TBL] [Abstract][Full Text] [Related]
32. Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women.
Bell RJ; Donath S; Davison SL; Davis SR
Menopause; 2006; 13(1):65-71. PubMed ID: 16607100
[TBL] [Abstract][Full Text] [Related]
33. Plasma organochlorine levels and subsequent risk of breast cancer among Japanese women: a nested case-control study.
Iwasaki M; Inoue M; Sasazuki S; Kurahashi N; Itoh H; Usuda M; Tsugane S;
Sci Total Environ; 2008 Sep; 402(2-3):176-83. PubMed ID: 18555519
[TBL] [Abstract][Full Text] [Related]
34. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies.
Geier DA; Geier MR
Neuro Endocrinol Lett; 2007 Oct; 28(5):565-73. PubMed ID: 17984958
[TBL] [Abstract][Full Text] [Related]
35. Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis.
Soman M; Huang LC; Cai WH; Xu JB; Chen JY; He RK; Ruan HC; Xu XR; Qian ZD; Zhu XM
Menopause; 2019 Jan; 26(1):78-93. PubMed ID: 29994966
[TBL] [Abstract][Full Text] [Related]
36. Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition.
Baglietto L; English DR; Hopper JL; MacInnis RJ; Morris HA; Tilley WD; Krishnan K; Giles GG
Breast Cancer Res Treat; 2009 May; 115(1):171-9. PubMed ID: 18509757
[TBL] [Abstract][Full Text] [Related]
37. Serum gonadotropins and steroid hormones and the development of ovarian cancer.
Helzlsouer KJ; Alberg AJ; Gordon GB; Longcope C; Bush TL; Hoffman SC; Comstock GW
JAMA; 1995 Dec; 274(24):1926-30. PubMed ID: 8568986
[TBL] [Abstract][Full Text] [Related]
38. A prospective study of the transient decrease in ovarian cancer risk following childbirth.
Liu Q; Lambe M; Baik I; Cnattingius S; Riman T; Ekbom A; Adami HO; Hsieh CC
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2508-13. PubMed ID: 17164377
[TBL] [Abstract][Full Text] [Related]
39. High Androgens in Postmenopausal Women and the Risk for Atherosclerosis and Cardiovascular Disease: The Rotterdam Study.
Meun C; Franco OH; Dhana K; Jaspers L; Muka T; Louwers Y; Ikram MA; Fauser BCJM; Kavousi M; Laven JSE
J Clin Endocrinol Metab; 2018 Apr; 103(4):1622-1630. PubMed ID: 29408955
[TBL] [Abstract][Full Text] [Related]
40. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
